Jacobs Levy Equity Management, Inc Amneal Pharmaceuticals, Inc. Transaction History

Jacobs Levy Equity Management, Inc

$24.2 Billion
Q2 2025

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$6.42 - $8.83 $1.22 Million - $1.68 Million	-189,881 Reduced 66.1%	97,379 $810,000
Q2 2024 Aug 14, 2024	SELL	$5.36 - $7.11 $310,815 - $412,294	-57,988 Reduced 16.8%	287,260 $1.82 Million
Q1 2024 May 15, 2024	SELL	$5.24 - $6.34 $288,121 - $348,604	-54,985 Reduced 13.74%	345,248 $2.09 Million
Q4 2023 Feb 14, 2024	BUY	$3.36 - $6.21 $1.01 Million - $1.87 Million	300,832 Added 302.64%	400,233 $2.43 Million
Q3 2023 Nov 16, 2023	BUY	$2.76 - $4.59 $198,650 - $330,365	71,975 Added 262.43%	99,401 $419,000
Q2 2023 Aug 14, 2023	SELL	$1.33 - $3.1 $2.6 Million - $6.05 Million	-1,953,020 Reduced 98.62%	27,426 $85,000
Q1 2023 May 15, 2023	BUY	$1.27 - $2.7 $353,581 - $751,709	278,411 Added 16.36%	1,980,446 $2.75 Million
Q4 2022 Feb 14, 2023	BUY	$1.96 - $2.61 $509,061 - $677,882	259,725 Added 18.01%	1,702,035 $3.39 Million
Q3 2022 Nov 15, 2022	SELL	$2.02 - $3.62 $165,369 - $296,354	-81,866 Reduced 5.37%	1,442,310 $2.91 Million
Q2 2022 Aug 15, 2022	SELL	$3.01 - $4.46 $191,977 - $284,458	-63,780 Reduced 4.02%	1,524,176 $4.85 Million
Q1 2022 May 16, 2022	SELL	$3.9 - $4.89 $441,093 - $553,063	-113,101 Reduced 6.65%	1,587,956 $6.62 Million
Q4 2021 Feb 14, 2022	SELL	$3.95 - $5.85 $715,459 - $1.06 Million	-181,129 Reduced 9.62%	1,701,057 $8.15 Million
Q3 2021 Nov 15, 2021	SELL	$4.31 - $5.64 $938,493 - $1.23 Million	-217,748 Reduced 10.37%	1,882,186 $10.1 Million
Q2 2021 Aug 16, 2021	BUY	$5.12 - $6.82 $2.24 Million - $2.98 Million	436,882 Added 26.27%	2,099,934 $10.8 Million
Q1 2021 May 17, 2021	BUY	$4.74 - $7.38 $4.49 Million - $7 Million	948,233 Added 132.65%	1,663,052 $11.2 Million
Q4 2020 Feb 16, 2021	BUY	$3.95 - $5.42 $1.64 Million - $2.25 Million	414,546 Added 138.06%	714,819 $3.27 Million
Q3 2020 Nov 16, 2020	BUY	$3.54 - $5.27 $814,992 - $1.21 Million	230,224 Added 328.66%	300,273 $1.17 Million
Q2 2020 Aug 17, 2020	SELL	$2.87 - $5.46 $510,070 - $970,378	-177,725 Reduced 71.73%	70,049 $333,000
Q1 2020 May 15, 2020	BUY	$2.46 - $5.35 $609,524 - $1.33 Million	247,774 New	247,774 $862,000
Q4 2019 Feb 14, 2020	SELL	$2.65 - $5.56 $531,590 - $1.12 Million	-200,600 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$2.29 - $7.1 $379,682 - $1.18 Million	165,800 Added 476.44%	200,600 $582,000
Q2 2019 Aug 13, 2019	BUY	$6.44 - $14.29 $224,112 - $497,291	34,800 New	34,800 $250,000

Others Institutions Holding AMRX

# of Institutions

248

Shares Held

144M

Call Options Held

194K

Put Options Held

49.3K

Vanguard Group Inc Valley Forge, PA

17.6M
Shares

$158 Million
0.0% of portfolio
Tpg Gp A, LLC Fort Worth, TX

12.3M
Shares

$111 Million
6.02% of portfolio
Rubric Capital Management LP New York, NY

11.7M
Shares

$106 Million
2.18% of portfolio
Black Rock Inc. New York, NY

11.3M
Shares

$102 Million
0.0% of portfolio
Ken Griffin Citadel Advisors LLC | Chicago, Il

5.62M
Shares

$50.7 Million
0.01% of portfolio

View Full List

About Amneal Pharmaceuticals, Inc.

Ticker AMRX
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 151,408,992
Market Cap $1.37B
Description
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...

More about AMRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.

Account